Title
Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses
UMMS Affiliation
Department of Medicine, Division of Hematology/Oncology
Publication Date
12-1-1976
Document Type
Article
Subjects
Adenoma, Islet Cell; Diarrhea; Female; Humans; Hypokalemia; Middle Aged; Pancreatic Neoplasms; Stomach Diseases; Streptozocin; Syndrome; Vasoactive Intestinal Peptide
Disciplines
Life Sciences | Medicine and Health Sciences | Women's Studies
Abstract
A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the pancreas (Verner-Morrison syndrome) was found to have an elevated vasoactive intestinal peptide (VIP) concentration in the plasma as well as in the tumor. Treatment with streptozocin resulted in a dramatic subjective and objective tumor response in this patient. Plasma VIP concentration fell into the normal range after four courses of treatment, diarrhea ceased after the third course of therapy, and measurable tumor mass markedly decreased during that same period of time. The patient remains in clinical remission with no evidence of tumor regrowth 18 months after the beginning of treatment. In this patient, plasma VIP measurements were an excellent marker of tumor activity and correlated well with objective disease measurements and clinical response.
Source
Arch Intern Med. 1976 Dec;136(12):1429-35.
Journal/Book/Conference Title
Archives of internal medicine
Related Resources
PubMed ID
187136
Repository Citation
Gagel, R. F.; Costanza, Mary E.; DeLellis, R. A.; Norton, R. A.; Bloom, S. R.; Miller, H. H.; Ucci, A.; and Nathanson, L., "Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses" (1976). Women’s Health Research Faculty Publications. 82.
https://escholarship.umassmed.edu/wfc_pp/82
